IPhO is the organization whose pharmacist members are universally recognized within the pharmaceutical industry as being the most professionally equipped to contribute to the development, commercialization, promotion, and optimal use of medicines.
What was your motivation to pursue the pharmaceutical industry as a career path?
From my awareness of the industry, I knew that becoming a medical science liaison would be the ideal role for me as it is the perfect blend of communication, science, and relationship building. As an MSL, I have the opportunity to share complex scientific information in different ways to various audiences. I have always found that my strengths lie in emotional intelligence and the ability to build strong relationships, both of which are key to succeeding in this role.
An unforgettable milestone like a 50th podcast episode calls for an unforgettable guest—and once again, our team delivered! We are honored to welcome David Epstein, seasoned pharmaceutical executive, innovator, and trailblazer, to the show!
Throughout his transformative career, David has led teams to develop and launch over 30 new medications worldwide. Currently, he serves as Chairman of the Board at Agomab, where he continues to drive strategic initiatives and support groundbreaking advancements in the field. Previously, he led Seagen through a period of marked growth and success as Chief Executive Officer—culminating in its merger with Pfizer.
If there's anyone who knows what it takes to rise through the ranks, push boundaries, motivate and inspire others, and enjoy a truly life-changing career, it's David. And you can learn from him by tuning in!
_67289.png)
